You have 9 free searches left this month | for more free features.

vemurafenib

Showing 1 - 25 of 94

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Tampa (XL888, Vemurafenib)

Active, not recruiting
  • Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 18, 2022

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Vemurafenib
  • Paris, France
    Tredaniel
May 18, 2022

Melanoma Trial in Ottawa, Toronto, Montreal (Vemurafenib, Cobimetinib)

Active, not recruiting
  • Melanoma
  • Ottawa, Ontario, Canada
  • +2 more
Oct 25, 2022

Histiocytosis Trial in Warsaw (Vemurafenib)

Recruiting
  • Histiocytosis
  • Vemurafenib
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Aug 2, 2022

Melanoma Trial in Beijing (HL-085, Vemurafenib)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 10, 2022

Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)

Active, not recruiting
  • Thyroid Carcinoma
  • Vemurafenib
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 28, 2022

Melanoma Trial in Napoli (Vemurafenib, Peg-interferon, Cobimetinib)

Completed
  • Melanoma
  • Vemurafenib
  • +2 more
  • Napoli, Italy
    Fondazione G.Pascale
Feb 23, 2022

Melanoma Trial in Pittsburgh (Pembrolizumab, Vemurafenib, Cobimetinib)

Terminated
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center Hillman Cancer Center
Dec 10, 2021

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Melanoma Trial in Louisville (Vemurafenib, Metformin)

Recruiting
  • Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center-University of Louisville
Oct 22, 2021

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Solid Tumor Trial in Beijing, Zhengzhou, Hangzhou (HL-085, Vemurafenib)

Recruiting
  • Solid Tumor
  • Beijing, Beijing, China
  • +3 more
Jan 20, 2022

Pancreas Cancer Trial in Scottsdale (Vemurafenib, Sorafenib)

Recruiting
  • Pancreas Cancer
  • Scottsdale, Arizona
    HonorHealth Research Institute
Oct 28, 2021

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting
  • Solid Tumor
  • +11 more
  • Belfast, United Kingdom
  • +16 more
Mar 2, 2023

Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

Active, not recruiting
  • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
  • Vemurafenib
  • Los Angeles, California
  • +20 more
Jan 4, 2023

Colorectal Cancer Trial in Shanghai (Vemurafenib, Cetuximab)

Recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Aug 15, 2021

CRC Trial in Beijing (HL-085, Vemurafenib)

Not yet recruiting
  • CRC
  • Beijing, Beijing, China
    Beijing Oncology Hospital
Feb 6, 2022

Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

Recruiting
  • Thyroid Carcinoma
  • +5 more
  • I-124 PET/CT lesion dosimetry
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2022

Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

Active, not recruiting
  • Hairy Cell Leukemia
  • +2 more
  • New Haven, Connecticut
  • +8 more
Feb 7, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Melanoma, Melanoma (Skin), Melanoma Stage Trial in Napoli (Vemurafenib, Cobimetinib)

Terminated
  • Melanoma
  • +2 more
  • Napoli, Italy
    Fondazione G.Pascale
Apr 23, 2021

NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

Recruiting
  • Non-small Cell Lung Cancer
  • London, United Kingdom
    Univeristy College London Hospital
Feb 22, 2022

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Vemurafenib
  • +7 more
  • Berlin, Germany
  • +5 more
Jan 2, 2023

Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

Recruiting
  • Rare Tumor
  • Refractory Tumor
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Feb 16, 2022

Targeted Therapies in BRAF Positive Metastatic Melanoma in US

Active, not recruiting
  • Melanoma
  • New York, New York
    Pfizer Investigational Site
Feb 18, 2022